SCHEMBL4758489

SCHEMBL4758489

NNC(=O)CNC(=O)c1ccc(O)cc1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.72
GFER P55789 2/20 0.72
CES2 O00748 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
TSHR P16473 1/20 0.46
KDM4E B2RXH2 2/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 1/20 0.45
HSP90AB1 P08238 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK4 Q16654 1/20 0.45
EGLN1 Q9GZT9 1/20 0.44
PTGS1 P23219 1/20 0.44
SERPINE1 P05121 1/20 0.44
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1303113 0.84 ALDH1A1 (1.00) ALDH1A1GFERCES2CA12CA1
SCHEMBL23484439 0.79 ALDH1A1 (0.69) ALDH1A1GFERCES2CA12CA1
SCHEMBL7898215 0.79 ALDH1A1 (0.59) ALDH1A1GFERCES2CA12CA1
SCHEMBL10825503 0.76 HIF1A (0.68) ALDH1A1GFERCA12CA1CA2
SCHEMBL4913264 0.75 ALDH1A1 (0.62) ALDH1A1GFERCES2CA12CA1
SCHEMBL3082235 0.74 ALDH1A1 (0.46) ALDH1A1GFERMEN1GAAKMT2A
Hydrochloric Acid SCHEMBL23067451 0.74 ALDH1A1 (0.41) ALDH1A1GFERKDM4EHTTLMNA
SCHEMBL4756419 0.74 CA12 (0.60) ALDH1A1GFERCA12CA1CA2
SCHEMBL23067305 0.72 HDAC6 (0.53) ALDH1A1GFERCA12CA1CA2
SCHEMBL28670130 0.72 CDK1 (0.59) ALDH1A1GFERCES2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008011557-A2 HETEROARYL INHIBITORS OF RHO KINASE BORCHARDT ALLEN J (US) 2008-01-24 WO disclosed
WO-2008011557-A2 HETEROARYL INHIBITORS OF RHO KINASE BORCHARDT ALLEN J (US) 2008-01-24 WO disclosed
US-20080021217-A1 HETEROCYCLIC INHIBITORS OF RHO KINASE Borchardt, Allen (US) 2008-01-24 US disclosed
US-20080021217-A1 HETEROCYCLIC INHIBITORS OF RHO KINASE Borchardt, Allen (US) 2008-01-24 US disclosed
US-20080021217-A1 HETEROCYCLIC INHIBITORS OF RHO KINASE Borchardt, Allen (US) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021217-A1 HETEROCYCLIC INHIBITORS OF RHO KINASE ROCK1, ROCK2, RHOA ALDH1A1 3968/4885GFER 3282/4885CES2 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.